Lisata Therapeutics, Inc.
17
0
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
35.3%
6 terminated/withdrawn out of 17 trials
62.5%
-24.0% vs industry average
12%
2 trials in Phase 3/4
50%
5 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Role: lead
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Role: lead
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
Role: lead
CLBS119 for Repair of COVID-19 Induced Pulmonary Damage
Role: lead
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
Role: lead
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
Role: lead
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Role: lead
Vaccine Therapy in Treating Patients With Kidney Cancer
Role: lead
ACT34-CMI -- Adult Autologous CD34+ Cells
Role: lead
Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
Role: lead
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Role: lead
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Role: lead
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Role: lead
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Role: lead
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Role: lead
NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction
Role: lead
Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
Role: lead
All 17 trials loaded